Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 11, Novembre 2013
Page(s) 954 - 956
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20132911008
Publié en ligne 20 novembre 2013
  1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008 ; 454 : 436–444. [CrossRef] [PubMed]
  2. Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 2006 ; 45 : 744–757. [CrossRef] [PubMed]
  3. Yu LX, Yan HX, Liu Q, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010 ; 52 : 1322–1333. [CrossRef] [PubMed]
  4. Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012 ; 21 : 504–516. [CrossRef] [PubMed]
  5. Wang Z, Yan J, Lin H, et al. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Hepatology 2013 ; 57 : 1869–1881. [CrossRef] [PubMed]
  6. Zhang HL, Yu LX, Yang W, et al. Profound impact of gut homeostasis on chemically induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 2012 ; 57 : 803–812. [CrossRef] [PubMed]
  7. McKnite AM, Perez-Munoz ME, Lu L, et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012 ; 7 : e39191. [CrossRef] [PubMed]
  8. Friswell MK, Gika H, Stratford IJ, et al. Site and strain-specific variation in gut microbiota profiles, metabolism in experimental mice. PLoS One 2010 ; 5 : e8584. [CrossRef] [PubMed]
  9. Agundez JA, Garcia-Martin E, Devesa MJ, et al. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology 2012 ; 82 : 35–40. [CrossRef] [PubMed]
  10. Liang B, Chen R, Wang T, et al. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma. Clin Cancer Res 2013 ; 19 : 2905–2916. [CrossRef] [PubMed]
  11. Burcelin R, Chabo C, Blasco-Baque V, et al. Le microbiote intestinal à l’origine de nouvelles perspectives thérapeutiques pour les maladies métaboliques ? Med Sci (Paris) 2013 ; 29 : 800–806. [CrossRef] [EDP Sciences] [PubMed]
  12. Hoarau G, Colombel JF, Poulain D, Sendid B. Implication de la flore fongique intestinale dans le développement de la maladie de Crohn. Med Sci (Paris) 2013 ; 29 : 691–693. [CrossRef] [EDP Sciences] [PubMed]
  13. Imler JL, Ferrandon D. Le printemps de l’immunité innée couronné à Stockholm. Med Sci (Paris) 2011 ; 27 : 1019–1024. [CrossRef] [EDP Sciences] [PubMed]
  14. Jamilloux Y, Henry T. Les inflammasomes : plates-formes de l’immunité innée. Med Sci (Paris) 2013 ; 29 : 975–984. [CrossRef] [EDP Sciences] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.